Truvestments Capital’s SpringWorks Therapeutics SWTX Stock Holding History

Truvestments Capital’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-356	Closed	-$16.7K	–	1116
2025 Q2	$16.7K	Buy	+356	New	+$15.8K	﹤0.01%	564

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Truvestments Capital's SWTX Position: Q3 2025 in Review

Truvestments Capital sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 356 shares — an estimated $16.7K sold.

Truvestments Capital first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $16.7K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Truvestments Capital reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Truvestments Capital sold 356 SpringWorks Therapeutics shares in Q3 2025, an estimated $16.7K.
Truvestments Capital first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Truvestments Capital's SpringWorks Therapeutics position peaked at $16.7K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Truvestments Capital's 13F filing for Q3 2025, filed 14 Nov 2025.